IRON Latest Headlines

Disc Medicine: Emerging Strength in Rare Hematologic Data Supports Buy Rating and Multi-Asset Growth Platform

at www.tipranks.com (Fri, 11-Sep 8:35 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Disc Medicine (IRON), TransMedics Group (TMDX) and Lyell Immunopharma (LYEL)

at www.tipranks.com (Fri, 11-Sep 8:02 AM)

Disc Medicine reports promising DISC-3405 Phase 2 data

at www.tipranks.com (Thu, 10-Sep 9:19 AM)

Analysts Are Bullish on These Healthcare Stocks: COMPASS Pathways (CMPS), Ocugen (OCGN)

at www.tipranks.com (Thu, 10-Sep 7:50 AM)

Disc Medicine Maintained at Buy as Analyst Reiterates Unchanged $100 Price Target on Promising RESTORE-PV Data and Undervalued Pipeline

at www.tipranks.com (Thu, 10-Sep 7:35 AM)

Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS) and Disc Medicine (IRON)

at www.tipranks.com (Thu, 10-Sep 7:00 AM)